Related Experiment Videos
Primary care diabetes in Norway.
Anne Karen Jenum1, Tor Claudi, John Graham Cooper
1Oslo Diabetes Research Centre, Aker University Hospital, University of Oslo, 0514 Oslo, Norway. a.k.jenum@medisin.uio.no
Primary Care Diabetes
|August 6, 2008
Summary
Patients with type 1 diabetes see specialists, while type 2 diabetes patients receive primary care. Quality of diabetes care is improving with new national guidelines forthcoming.
Area of Science:
- Endocrinology
- Internal Medicine
- Primary Care
Background:
- Current treatment models for type 1 diabetes involve specialists after age 16-18.
- Type 2 diabetes management is typically handled within primary care settings.
- Healthcare quality for diabetes patients has seen documented improvements.
Purpose of the Study:
- To summarize current treatment pathways for type 1 and type 2 diabetes.
- To highlight improvements in the quality of diabetes care.
- To inform about upcoming national clinical guidelines.
Main Methods:
- Review of existing treatment protocols for diabetes management.
- Analysis of quality of care trends in diabetes.
- Monitoring of national health strategy implementation.
Main Results:
- Distinct care pathways exist for type 1 and type 2 diabetes based on age and type.
- Significant improvements in the overall quality of diabetes care have been observed.
- A National Diabetes Strategy initiated in 2006 is ongoing.
Conclusions:
- The current system effectively routes patients to appropriate care levels.
- Ongoing efforts and new guidelines are expected to further enhance diabetes management.
- The national strategy signifies a commitment to improving diabetes outcomes.
Related Concept Videos
01:15Diabetes: Management and Pharmacotherapy
The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
01:15Diabetes: Symptoms, Diagnosis, and Complications
For most patients, experiencing several weeks of polyuria, polydipsia, fatigue, and significant weight loss may indicate the presence of diabetes. Furthermore, adults displaying the phenotypic appearance of type 2 diabetes (particularly those who are obese and not initially insulin-requiring), may have islet cell autoantibodies, suggesting autoimmune-mediated β cell destruction and a diagnosis of latent autoimmune diabetes of adults (LADA). The categorization of glucose homeostasis is based on...
01:22Diabetes Mellitus: Type 2 and Gestational
Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
01:25Type II Diabetes Mellitus III: Clinical Manifestations and Diagnosis
Type 2 diabetes mellitus develops gradually and is often asymptomatic in early stages.Clinical ManifestationsWhen symptoms appear, they include fatigue, blurred vision, pruritus, delayed wound healing, and recurrent infections, particularly candidal infections. Peripheral neuropathy may present as numbness or tingling in the extremities. Classic hyperglycemia symptoms—polyuria, polydipsia, and polyphagia—are less common. Most patients are overweight and frequently have associated hypertension...
01:26Diabetes Mellitus: Introduction
Diabetes mellitus consists of chronic metabolic disorders characterized by persistent hyperglycemia. This elevated blood glucose results from defects in insulin secretion, impaired insulin action, or both. Insulin, produced by pancreatic β-cells, is essential for maintaining glucose homeostasis by facilitating cellular glucose uptake for energy or storage. Disruptions in insulin production or function lead to glucose accumulation in the bloodstream, causing the clinical features and long-term...
01:26Type II Diabetes I: Introduction
Type 2 diabetes mellitus (T2DM) is a chronic metabolic disorder characterized by insulin resistance, in which target tissues such as the liver, muscle, and adipose tissue respond poorly to insulin. It is also associated with inadequate compensatory insulin secretion, where pancreatic β-cells fail to produce sufficient insulin. Together, these abnormalities lead to persistent hyperglycemia.EtiologyT2DM develops through a complex interaction of genetic predisposition and environmental or...